Trevena Presents Phase 1 Clinical Data for TRV027, a ²-arrestin Biased AT1R Ligand, at the 2012 ...
06:37 EDT 9 Sep 2012 | LaMerie
Original Article: Trevena Presents Phase 1 Clinical Data for TRV027, a ²-arrestin Biased AT1R Ligand, at the 2012 ...
More From BioPortfolio on "Trevena Presents Phase 1 Clinical Data for TRV027, a ²-arrestin Biased AT1R Ligand, at the 2012 ..."
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
